arrow
S

Stephen Lake

Harvard University
H指数:31
被引数:8,707

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
LANCET
IF88.5
2012-11-01943
PREAI
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
LANCET
IF88.5
2012-11-01959
PREAI
A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease.
2010-04-15545
OA